Davis Polk advised Roivant Sciences Ltd. in the deal, while Covington represented the underwriter, Cantor Fitzgerald. Roivant Sciences Ltd. announced its debut SEC-registered offering of 30,000,000...
You must be a Standard 1 Year member to access this content.
Covington represented the underwriters on the deal. Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders,...
You must be a Standard 1 Year member to access this content.
Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Latham successfully represented Cantor Fitzgerald, L.P., CF Group Management Inc. (together with Cantor Fitzgerald, L.P., Cantor), and Howard Lutnick in the lawsuit. On August 19, 2022,...
You must be a Standard 1 Year member to access this content.
Miller Thomson acted as Canadian counsel to the Sales Agents. Village Farms International, Inc. (NASDAQ:VFF) announced that it has entered into a Controlled Equity Offering Sales Agreement...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the initial purchasers in the offering while Cooley advised Cytokinetics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, has announced the pricing of its...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Chinook Therapeutics, Inc. (Nasdaq: KDNY) has announced the pricing of its underwritten public offering of 6,428,572 shares...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents in the transaction. The transaction consists in a new SEC-registered at-the-market offering program by Denali Therapeutics Inc. under which Denali...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the transaction. Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins, Stibbe and Maples and Calder advised Brigade-M3 European Acquisition Corp on the deal. Linklaters advised Cantor Aurel and Cantor Fitzgerald Europe. Brigade-M3 European...
You must be a Standard 1 Year member to access this content.
Latham& Watkins advised Blade, Ellenoff Grossman & Schole advised BAC, and Simpson Thacher & Bartlett advised Barclays and Cantor in their role as placement agents for...
You must be a Standard 1 Year member to access this content.
